Genialis is the RNA biomarker company
We are creating a world where healthcare delivers the best possible outcomes for patients, their families and communities.
Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.
People First
We mean People First in two ways
First is our commitment to personalizing medicine for the benefit of patients by modeling fundamental biology through the use of human data.
Second, and equally important, is how we build our team and orchestrate our work lives. People first is Genialis’ principal core value, our north star.
Meet our leadership team
Rafael Rosengarten, Ph.D.
Chief Executive Officer and Co-founder
Rafael leads Genialis’ effort to realize the promise of precision medicine, and to build a company that puts people first as a guiding principle. Prior to Genialis, he spent nearly 20 years in biomedical research, publishing on the evolution of innate immune systems, bioengineering of microbes, and genetics of development. Rafael co-invented the j5 DNA assembly design automation software for high-throughput molecular design and analyses (since commercialized by TeselaGen). Rafael earned his doctorate at Yale University, and conducted his postdoctoral research at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI) and Baylor College of Medicine.
Miha Štajdohar, Ph.D.
Chief Technology Officer and Co-founder
Miha leads data science and software development R&D towards the overarching goal of embedding artificial intelligence in medical device software, such as clinical biomarkers. Designing data integration and (X)AI systems he co-invented and patented technologies on bias adjustment (since commercialized by Genialis as Data Flywheel). Focusing on projects that integrate his background in machine learning and network science, he co-developed Orange data mining suite and Resolwe data flow engine for bioinformatics pipelining. Miha earned his doctorate in computer science at University of Ljubljana, and conducted his postdoctoral research at Baylor College of Medicine.
Tjaša Krisper Kutin
Chief Operating Officer
Tjaša is a professional with 15 years of experience in business operations, finance, people operations, and compliance. She is versed in the needs of companies big and small. Previously, she led the GDPR consulting arm of a company servicing heavily-regulated industries such as pharma and healthcare. Prior to that, Tjaša was a founder of a Wayra-accelerated startup, and led the operations team of an Insurance industry startup. Now, Tjaša is responsible for translating Genialis’ values into a rewarding and impactful work environment. She earned her degree in international relations from the University of Ljubljana, with a focus on corporate responsibility.
Luka Ausec, Ph.D.
Chief Discovery Officer
Luka directs internal R&D and external partner projects, with the common goal of advancing therapeutic discovery through the rigorous application of data science. Luka’s expertise in biology and computational disciplines makes him uniquely adept at innovating solutions at this nexus. He believes a successful discovery process is built on clear lines of communication and unwavering scientific integrity. In addition, Luka oversees the implementation of Genialis’ informatics platform, and manages the team that helps customers engage directly via Genialis software. Luka earned his doctorate in molecular biology and biotechnology at the University of Ljubljana.
Board of Directors
Rafael Rosengarten, PhD
CEO and Co-founder
Genialis
Miha Štajdohar, PhD
CTO and Co-founder
Genialis
Krista McKerracher
Chairperson
Elia Stupka, PhD
Managing Director
Angelini Ventures
Cédric Odje
Investment Associate
Debiopharm
Ita Lu
Managing Partner
Taiwania Capital